Compare Vanguard Value Index Fund ETF (VTV) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Value Index Fund ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Vanguard Value Index Fund ETF trades at $218.54, while State Street SPDR S&P Biotech ETF trades at $154.42. Which is the better fit depends on your goals.
| VTV | XBI | |
|---|---|---|
52-Week High | $220.51 | $164.28 |
52-Week Low | $175.51 | $85.16 |
Sector | — | Broad Market / Factor |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
